• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fabino Enterprises Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 76237.0
  • ISIN : INE0DRT01018
20.31 1 (4.96%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    20.31

  • Today’s High

    20.31

  • Open

    20.31

  • Perv Close

    19.35

  • 52W Low

    13.01

  • 52W High

    27.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    4.27

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.71

  • Debt-Equity Ratio

    4.96

  • AGM Date

    27-Apr-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.20

  • Mar.Cap (₹Cr.)

    4.27

  • RONW (%)

    0.97

  • ROCE (%)

    1.80

Score Board

  • Equity (₹ in Cr.)

    2.10

  • BV (₹)

    18.70

  • Sales( ₹ in Cr.)

    11.43

  • NP (in Cr.)

    -0.36

  • NP Var(%)

    -373.0

  • Div%

    0.0

  • CPS (₹)

    -1.20

  • EPS (₹)

    -1.70

  • Traded Value (₹ in Lakhs)

    4.27

  • 52 Week High

    27.00

  • 52 Week Low

    13.01

  • Price BSE

    20.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    4.27

  • P/C Ratio

    -16.40

  • P/E Ratio

    -11.70

  • Price Vs.BV

    -1.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 18.04 6.08 3.36 4.20 3.06 7.52
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 18.04 6.08 3.36 4.20 3.06 7.52
Other Income 0.29 0.00 0.02 0.01 0.00 0.00
Stock Adjustments -0.13 0.15 -0.52 1.24 0.17 -4.63
Total Income 18.20 6.23 2.86 5.45 3.23 2.89
EXPENDITURE :            
Raw Materials 16.36 5.63 2.43 4.81 2.91 2.26
Power and Fuel Cost 0.04 0.00 0.01 0.00 0.03 0.00
Employee Cost 0.27 0.16 0.19 0.19 0.09 0.21
Other Manufacturing Expenses 0.51 0.05 0.00 0.02 0.00 0.00
Selling and Administration Expenses 0.29 0.16 0.15 0.31 0.13 0.00
Miscellaneous Expenses 0.27 0.12 0.02 0.01 0.02 0.10
Employee Benefit Expenses 0.27 0.16 0.19 0.19 0.09 0.21
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 17.74 6.13 2.81 5.35 3.17 2.57
Operating Profit 0.46 0.11 0.05 0.11 0.07 0.32
Interest 0.13 0.02 0.01 0.01 0.01 0.20
Gross Profit 0.33 0.09 0.04 0.10 0.06 0.12
Depreciation 0.07 0.03 0.03 0.03 0.02 0.02
Profit Before Tax 0.26 0.06 0.01 0.07 0.04 0.10
Current Tax 0.13 0.01 0.00 0.02 0.01 0.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.13 0.05 0.01 0.05 0.03 0.07
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.13 0.05 0.01 0.05 0.03 0.07
Adjustment below Net Profit 0.00 -0.01 0.00 0.00 -0.05 0.00
P & L Balance brought forward 0.20 0.16 0.15 0.10 0.12 0.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.34 0.20 0.16 0.15 0.10 0.12
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.63 0.23 0.05 0.22 0.25 4.59
Earnings Per Share(Adj)-Unit Curr 0.63 - 0.05 0.22 - -
Book Value 20.42 19.80 19.59 19.54 10.86 44.84
Book Value(Adj)-Unit Curr 20.42 - 19.59 19.54 - -

Shareholding Pattern

  • Promoter Group

    56.82%

  • Public Share Holding

    43.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 93,200 4.44 93,200 4
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,100,000 52.38 1,100,000 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,193,200 56.82 1,193,200 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 150,000 7.14 150,000 3
Clearing Members 12,000 0.57 12,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 9,000 0.43 9,000 2
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 48,000 2.29 48,000 9
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 231,000 11.00 231,000 7
Individuals holding nominal share capital up to Rs. 1 lakh 456,800 21.75 456,800 114
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 906,800 43.18 906,800 136
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,100,000 100.00 2,100,000 141

Company Background

Fabino Enterprises LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Fabino Enterprises Ltd
  • BSE Code : 76237.0
  • ISIN : INE0DRT01018

  • Incorporation Year

    2011

  • Registered Office

    105 1st Floor Barodia Tower
    Central Market Prashant Vihar, New Delhi,
    New Delhi-110085

  • Telephone

    +91-988390021/9215324221

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    anand katarmal

  • Auditor

    D G M S & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar


    ,
    ,
    Mumbai -

Fabino Enterprises Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fabino Enter 20.31 18.32 18.04 -11.88 7.13
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77